← Back to Clinical Trials
Recruiting NCT06818201

NCT06818201 Effects of tDCS on Motor Cortex During ACL Recovery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06818201
Status Recruiting
Phase
Sponsor Fundación Universidad Católica de Valencia San Vicente Mártir
Condition Anterior Cruciate Ligament Reconstruction Rehabilitation
Study Type INTERVENTIONAL
Enrollment 54 participants
Start Date 2025-11-28
Primary Completion 2027-12-27

Trial Parameters

Condition Anterior Cruciate Ligament Reconstruction Rehabilitation
Sponsor Fundación Universidad Católica de Valencia San Vicente Mártir
Study Type INTERVENTIONAL
Phase N/A
Enrollment 54
Sex ALL
Min Age 16 Years
Max Age 40 Years
Start Date 2025-11-28
Completion 2027-12-27
Interventions
NIBSRehabilitationSham Comparator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Anterior Cruciate Ligament (ACL) is a prevalent injury, particularly among young and physically active individuals. The efficacy of transcranial direct current stimulation (tDCS) and exercise-based rehabilitation on neuromuscular control in post-ACL reconstruction patients is evaluated, and these techniques are combined.

Eligibility Criteria

Inclusion Criteria: * Diagnosis complete ACL tear through clinical evaluation and MRI imaging. * Patients who have received surgical intervention. * Aged between 16 and 40 years. * Tegner activity level of 4 or higher. Exclusion Criteria: * Rupture, such as tendons, cartilage, bones, or ligaments. * Absence of any pre-existing or current lower limb pathologies, such as open surgeries, knee arthroscopies, or femur/tibia fractures. * Neuromuscular or metabolic diseases. * Concussion within the past six months are not eligible. * Cranial surgery or have intracranial metal clips are ineligible. * Taking medications that affect neuronal activity. * Neurological diseases or disorders are not eligible for participation.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology